PDLIM7 and Burkitt lymphoma: While EBV-transformed B-LCLs express viral antigens representing latency type III (10 viral proteins), these cells might not be useful for generating specific T cells that effectively target late PTLDs expressing latency type II [only three viral proteins EBV nuclear antigen-1 (EBNA-1), late membrane proteins (LMP) LMP1 and LMP2 expressed] or latency type I tumors (e.g., Burkitt's lymphoma) [see review in (Bollard et al., 2012)].